COMMUNIQUÉS West-GlobeNewswire

Albireo Recognizes PFIC Awareness Day and Highlights Urgent Needs of Progressive Familial Intrahepatic Cholestasis Families
03/10/2019
Grassroots PFIC community advocates to build awareness of rare, life-threatening liver disease BOSTON, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (NASDAQ: ALBO), a clinical-stage orphan pediatric liver [...]
Tonix Pharmaceuticals Announces Completion of Long-Term Exposure Studies in Participants with PTSD to Evaluate the Tolerability of TNX-102 SL 5.6 mg
03/10/2019
Company Expects this Long-Term Safety Exposure Data to Satisfy Long-Term Exposure Requirements for Potential New Drug Applications for TNX-102 SL for PTSD and Fibromyalgia NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- [...]
Kaleido Biosciences Presents Ex Vivo Data of KB109 Demonstrating Reduction of Multi-drug Resistant Pathogens at IDWeek 2019™
03/10/2019
Additional Presentation on Platform at Upcoming Keystone Symposia on the Microbiome: Therapeutic Implications LEXINGTON, Mass., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical- [...]
Mesoblast Completes Successful Institutional Capital Raising of A$75 Million
03/10/2019
NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO; ASX: MSB), leader in cellular medicines for inflammatory diseases, announced today that it has successfully completed a A$75 million (US$50.4 [...]
XBiotech annonce le premier patient dans une étude clinique visant à évaluer le bermekimab pour le traitement de la sclérose systémique
03/10/2019
Le bermekimab bloque la principale voie inflammatoire dans la sclérose systémique, une maladie dévastatrice, sans thérapie approuvée à l'heure actuelle AUSTIN, Texas, 03 oct. 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ : [...]
MediPharm Labs Sets Date to Announce Third Quarter 2019 Financial Results
03/10/2019
TORONTO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation [...]
Exactus, Inc. Launches E-Commerce Marketplace Through Exactushemp.com and Initiates Buy Back Program for Non-Traceable CBD Products
03/10/2019
DELRAY BEACH, Fla., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB:EXDI) (the “Company”), an industrial hemp farm operator and manufacturer of hemp-derived phytocannabinoid products, today announced that it has [...]
VIVUS Initiates Pay Down of Secured Debt and Announces Management Changes
03/10/2019
-Reduction of $48.6 million of Secured Debt will result in total interest savings of $10.5 million- -Organizational change streamlines commercial operations- CAMPBELL, Calif., Oct. 03, 2019 (GLOBE NEWSWIRE) -- VIVUS, [...]
vTv to Host Key Opinion Leader Event to Discuss the Type 1 Diabetes Treatment Landscape and Emerging Therapies as Adjuncts to Insulin
03/10/2019
HIGH POINT, N.C., Oct. 03, 2019 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), today announced that the Company will host a key opinion leader (KOL) presentation and webcast discussing the type 1 diabetes ( [...]
SIGA Completes Clinical Studies for IV Formulation of TPOXX®, NDA to be Submitted in 2020
03/10/2019
NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has reached concurrence [...]
ADMA Biologics Announces Poster Presentation at IDWeek 2019
03/10/2019
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 03, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin [...]
Aprea Therapeutics Announces Pricing of Initial Public Offering
03/10/2019
BOSTON, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53, [...]
Viela Bio Announces Pricing of Initial Public Offering
03/10/2019
GAITHERSBURG, Md., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Viela Bio, Inc., a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, today announced the pricing of its [...]
Organovo Acknowledges Receipt of Proposal
03/10/2019
Reiterates Commitment to Strategic Review Process SAN DIEGO, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO) (“Organovo”) today confirmed that it has received a proposal from Viscient [...]
Viome Named to the 2019 CB Insights Digital Health 150, List of Most Innovative Digital Health Startups
03/10/2019
Fast-growing healthcare company recognized for achievements in microbiome analysis and chronic disease prevention research SEATTLE, Oct. 02, 2019 (GLOBE NEWSWIRE) -- CB Insights today named Viome to the inaugural [...]
EyePoint Pharmaceuticals Announces Permanent and Specific J-Code for YUTIQ® Now in Effect
02/10/2019
WATERTOWN, Mass., Oct. 02, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, [...]
Aduro Biotech Announces Two Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer 34th Annual Meeting (SITC 2019)
02/10/2019
BERKELEY, Calif., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (STING) and [...]
Lexicon Pharmaceuticals Announces Poster Presentations at the NANETS Annual Multidisciplinary NET Medical Symposium
02/10/2019
THE WOODLANDS, Texas, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that data from five posters highlighting XERMELO ® (telotristat ethyl) will be presented at the [...]
Monthly information regarding the total number of voting rights and total number of shares of the Company
02/10/2019
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]

Pages